Drug Trial Radar · NCT05769608
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
Last checked: Nov 19, 2026Latest source record: Jan 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
285
Actual
Start
Mar 13, 2023
Primary completion
Jan 15, 2025
Study completion Jan 15, 2025
Sponsor
- Lead sponsor
- Mineralys Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 15, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2 trial to evaluate the blood pressure-lowering effect of lorundrostat an aldosterone synthase inhibitor (ASI), administered as an add-on to a standardized anti-hypertensive (AHT) medication regimen, in subjects with hypertension.
Conditions
- Hypertension
Interventions
PlaceboDrug
Placebo once daily for 12 weeks
lorundrostat Dose 1Drug
lorundrostat Dose 1 once daily for 12 weeks
lorundrostat Dose 2Drug
lorundrostat Dose 1 once daily for 4 weeks then lorundrostat Dose 2 once daily for 8 weeks for subjects who meet prespecified criteria
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in 24-hour average ambulatory blood pressure monitoring (ABPM) systolic blood pressure (SBP)Time frame: Baseline (Randomization) to Week 12
Locations
104 sites in 1 country. Site status is shown where the registry gives one.
Cardiology, P.C. - Birmingham
Birmingham, Alabama
University of Alabama at Birmingham (UAB) - Vascular Biology and Hypertension Program
Birmingham, Alabama
Chandler Clinical Trials
Chandler, Arizona
Brown Road Family Medicine
Mesa, Arizona
Scottsdale Clinical Trials (Elite Clinical Network)
Scottsdale, Arizona
Fiel Family & Sports Medicine
Tempe, Arizona
Noble Clinical Research
Tucson, Arizona
Del Sol Research Management, LLC
Tucson, Arizona
The Medical Research Group Inc.
Fresno, California
Marvel Clinical Research
Huntington Beach, California
University of California San Diego (UCSD) - Altman Clinical and Translational Research Institute (ACTRI)
La Jolla, California
Clinical Trials Research
Lincoln, California
Cedars-Sinai Medical Center
Los Angeles, California
Catalina Research Institute
Montclair, California
Northridge Clinical Trials
Northridge, California
University of California Irvine Medical Center
Orange, California
Triwest Research Associates
San Diego, California
San Jose Clinical Trials
San Jose, California
Blue Coast Research Center
Vista, California
Accelerated Enrollment Solutions (AES)- Vista
Vista, California
Delta Waves, Inc.
Colorado Springs, Colorado
CMR of Greater New Haven
Hamden, Connecticut
Indago Research & Health Center, Inc.
Hialeah, Florida
Clinical Neuroscience Solutions, Inc (Jacksonville)
Jacksonville, Florida
Reserka, LLC
Miami, Florida
Nuovida Research Center Corp
Miami, Florida
Clinical Neuroscience Solutions, INC.
Orlando, Florida
Patron Medical - Andres Patron D.O. (Patron Ventures, LLC)
Pembroke, Florida
Progressive Medical Research
Port Orange, Florida
Clinical Research of West Florida, Inc.
Tampa, Florida
The Pierone Research Institute (Elligo Health Research)
Vero Beach, Florida
Nephrology Associates, PC - Downtown Augusta
Augusta, Georgia
Accel Research Sites
Decatur, Georgia
Georgia Clinical Research, LLC
Lawrenceville, Georgia
Randomize Now
Peachtree City, Georgia
Alta Pharmaceutical Research Center
Peachtree Corners, Georgia
Fellows Research Alliance, Inc
Savannah, Georgia
Eagle Clinical Research
Chicago, Illinois
The University of Chicago Medicine
Chicago, Illinois
GenHarp Clinical Solutions
Evergreen Park, Illinois
Showing 40 of 104 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.